Next-Generation Biomanufacturing Market Recent Trends with Demand 2028

Next-Generation Biomanufacturing Market Increase in the number of biopharmaceutical companies across the nations is the key reason driving the growth of next-generation biomanufacturing in global market.


Emergen Research’s latest document, titled ‘Global Next-Generation Biomanufacturing Market - Forecast to 2028,’ is one of the most sought-after market reports involving an in-depth analysis of the global Next-Generation Biomanufacturing Market. The report’s authors have offered necessary details on the latest Next-Generation Biomanufacturing Market trends and the crucial parameters impacting both short-term and long-term market growth. Its panoramic view of the Next-Generation Biomanufacturing Market entails useful insights into the estimated Next-Generation Biomanufacturing Market size, revenue share, and sales distribution networks. Such helpful market insights are bound to help readers outline this ’s key outcomes in the near future.

The global next-generation biomanufacturing market is expected to reach a market size of USD 39.18 Billion by 2028, according to a recent analysis by Emergen Research. Next-generation biomanufacturing process makes it possible to meet increasing demand for biological medicine used in the treatment of critical diseases such as liver and kidney disorders, cancer and diabetes. In addition, growing adoption of single-use products such as single-use bio-reactors, bio containers and increasing financial support from private investors and governments for development of next-generation biomanufacturing units are among some major factors driving growth of the global next-generation biomanufacturing market, and the trend is expected to continue over the forecast period.

To Get a PDF Sample Copy of the Report, visit @

Further Key Findings in the Report:

  • In July 2018, Amgen opened a new next-generation biomanufacturing plant located in West Greenwich, R.I. campus. The company invested approximately USD 200 Million in this new facility.
  • In April 2020, Akron Biotech acquired Cambryn in Sarasota, Florida, from Cambryn Biologics. The facility is a biomanufacturing plant equipped with state-of-the-art equipment.
  • Biopharmaceutical Companies accounted for a 39% revenue share in the global market. This can be attributed to rapid technological advancements and increasing investor and governments funding.

Market Scope:

One of the report’s central components is the broad Next-Generation Biomanufacturing market segmentation that includes the product type gamut, application spectrum, end-user industry landscape, significant geographical regions, and the top market contenders. The report contains unbiased industry expert opinions on the current market scenario, past market performance, production consumption rates, demand supply ratio, and revenue generation forecasts over the estimated period. The key players’ financial positions, along with their gross profits, sales volumes, sales revenue, manufacturing costs, and other financial ratios, have been accurately gauged in the report. Furthermore, several analytical tools like investment assessment, SWOT analysis, and Porter’s Five Forces Analysis have been implemented by our analysts’ team to evaluate the production and distribution capacities of the Next-Generation Biomanufacturing market players.

Request a Sample Copy of the Report @

Highlights of the TOC: 

  1. Report Overview 
    1.1 Research Scope
    1.2 Key Next-Generation Biomanufacturing market segments
    1.3 Major players
    1.4 Market analysis by product
    1.5 Market analysis by application
    1.6 Report timeline
  2. Global Growth Trends 
    2.1 Global Next-Generation Biomanufacturing market size
    2.2 Latest Next-Generation Biomanufacturing market trends
    2.3 Key growth trends
  3. Competitive Landscape 
    3.1 Global Next-Generation Biomanufacturing market key players
    3.2 Global Next-Generation Biomanufacturing size by manufacturers
    3.3 Products of major players
    3.4 Entry barriers in the Next-Generation Biomanufacturing market
    3.5 Mergers, acquisitions, joint ventures, and strategic alliances

Leading Players Profiled in the Report:

Merck KGaA, Thermo Fisher Scientific Inc., Eppendorf AG, Danaher Corporation, GEA Group Aktiengesellschaft, Sartorius AG, bbi-biotech GmbH, Solaris Biotechnology Srl, Esco Group of Companies, Pierre Guérin, and PBS Biotech, Inc.

To get leading market solutions, visit the link below:

For the purpose of this report, Emergen Research has segmented the next-generation biomanufacturing market based on type, application, end-use, and region as follows:

Type Outlook (Revenue: USD Billion; 2020–-2028)

  • Continuous Upstream Biomanufacturing
  • Single-Use Upstream Biomanufacturing
  • Downstream Biomanufacturing

Application Outlook (Revenue: USD Billion; 2020–-2028)

  • Monoclonal Antibodies
  • Hormones
  • Vaccines
  • Recombinant Proteins
  • Others

End-Use Outlook (Revenue: USD Billion; 2020–-2028)

  • Biopharmaceutical Companies
  • Research Institutions
  • CMOs/CDMOs

Regional Outlook (Revenue: USD Billion; 2020–-2028)

  • North America
    1. S.
    2. Canada
  • Europe
    1. Germany
    2. K.
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East Africa
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

Gain Access to the Complete Report

Key questions addressed in the report:

  • What are the key factors driving the global Next-Generation Biomanufacturing market?
  • Who are the key manufacturers in this market space?
  • Who are the distributors, traders and dealers of this market?
  • What are the market opportunities and risks affecting the performance of the vendors in the global Next-Generation Biomanufacturing market?
  • What are the sales and revenue estimations for the top manufacturers in this market over the projected timeline?

Request customization of this report @

Thank you for reading our report. To find more details on the report or to inquire about its customization, please let us know, and we will offer you the report as per your needs.

Explore More Emergen Research Report @

Antimicrobial Susceptibility Testing/Antibiotic Sensitivity Testing Market-

Human Microbiome Market-

Molecular Imaging Market-

Tissue Engineering Market-

Bioelectric Medicine Market-

Infectious Disease Rapid Diagnostic Testing Market-

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Visit for More Insights:

Explore Our Custom Intelligence services | Growth Consulting Services

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release @